198 related articles for article (PubMed ID: 7889494)
1. Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.
Izumi H; Hirano S; Matsushita Y; Iguchi H; Tone H; Takeuchi T
Cancer Biochem Biophys; 1994 Sep; 14(2):137-49. PubMed ID: 7889494
[TBL] [Abstract][Full Text] [Related]
2. [In vitro combined effects of pirarubicin (THP) and various antitumor drugs on human tumor cell lines].
Nagasawa M; Ishii S; Kariya Y; Itoh O; Yamamoto H; Kawaharajo K; Takeuchi T
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):633-8. PubMed ID: 2108612
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Elliott WL; Roberts BJ; Howard CT; Leopold WR
Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
[TBL] [Abstract][Full Text] [Related]
4. [Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
Akamatsu K; Endo K; Tsunenari T; Matsumoto T; Kaiho S; Morikawa K; Koizumi M; Mitsui H; Koizumi K
Gan To Kagaku Ryoho; 1992 Feb; 19(2):229-35. PubMed ID: 1736835
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of pirarubicin and epirubicin in combination with doxifluridine and cisplatin against mouse P388 leukemia.
Agata N; Mase T; Izumi H; Hirano S; Iguchi H; Tone H; Takeuchi T
Cancer Biochem Biophys; 1995 Nov; 15(2):95-101. PubMed ID: 8590441
[TBL] [Abstract][Full Text] [Related]
6. Potentiation by vitamin A of the action of anticancer agents against murine tumors.
Nakagawa M; Yamaguchi T; Ueda H; Shiraishi N; Komiyama S; Akiyama S; Ogata J; Kuwano M
Jpn J Cancer Res; 1985 Sep; 76(9):887-94. PubMed ID: 3932288
[TBL] [Abstract][Full Text] [Related]
7. [Combined effect of CDDP with various types of antitumor drugs against P 388 leukemia].
Uchida T; Nishikawa K; Shibasaki C; Okamoto K; Arakawa M; Ekimoto H; Takahashi K
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2275-82. PubMed ID: 2735770
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
[TBL] [Abstract][Full Text] [Related]
9. [Fundamental study of combination chemotherapy with THP, 5-FU and CDDP for human KB carcinoma cell line and its multidrug resistant cell line KB-C1--usefulness of treatment with 5-FU preceding CDDP].
Kishimoto H; Manno Y; Tanaka H; Moridera K; Urade M
Gan To Kagaku Ryoho; 2001 Apr; 28(4):505-9. PubMed ID: 11329785
[TBL] [Abstract][Full Text] [Related]
10. [Effects of combination chemotherapy of MCNU with various anti-cancer agents].
Machida S; Ito Y; Hoshino A
Gan To Kagaku Ryoho; 1985 Feb; 12(2):298-302. PubMed ID: 3918506
[TBL] [Abstract][Full Text] [Related]
11. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
Li LH; DeKoning TF; Wallace TL
Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic synergy of trimetrexate (CI-898) in combination with doxorubicin, vincristine, cytoxan, 6-thioguanine, cisplatin, or 5-fluorouracil against intraperitoneally implanted P388 leukemia.
Leopold WR; Dykes DJ; Griswold DP
NCI Monogr; 1987; (5):99-104. PubMed ID: 2963231
[TBL] [Abstract][Full Text] [Related]
13. [Combination chemotherapy with 3 or 4 drugs on human breast and gastrointestinal cancer xenografts in nude mice (II)].
Fujita F; Fujita M; Sakamoto Y; Shimozuma K; Inaba H; Taguchi T
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1252-9. PubMed ID: 2953310
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of (2''R)-4'-O-tetrahydropyranyl adriamycin on human gastric cancer cell lines in vitro and in vivo.
Saikawa Y; Kubota T; Kuo TH; Furukawa T; Kase S; Tanino H; Ishibiki K; Kitajima M; Hoffman RM
Anticancer Res; 1994; 14(2A):469-73. PubMed ID: 8017850
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice].
Fujita F; Fujita M; Inaba H; Sugimoto T; Okuyama Y; Taguchi T
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2263-70. PubMed ID: 1929447
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of antitumor activity of pirarubicin by chlorpromazine in mice bearing doxorubicin-resistant P388 leukemia.
Shibata H; Maekawa I; Furusawa S; Kawauchi H; Takayanagi Y; Sasaki K
Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):359-62. PubMed ID: 2093213
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of combinations of interferons and cytotoxic drugs in murine tumor models in vivo.
Harrison SD; Stevens JJ; Waud WR; Dykes DJ; Schmid SM; Griswold DP
J Biol Response Mod; 1990 Aug; 9(4):395-400. PubMed ID: 2118561
[TBL] [Abstract][Full Text] [Related]
18. [Non-cross-resistant sequential combination chemotherapy consisting of cis-diammine-dichloroplatinum (II) mainly, based on synchronization theory, in human bladder cancer xenografts in athymic nude mice].
Yamauchi T; Okada K; Yoshida O
Hinyokika Kiyo; 1986 Dec; 32(12):1781-97. PubMed ID: 2435129
[TBL] [Abstract][Full Text] [Related]
19. [Combined effect of HO-221 with various antitumor agents against L 1210 leukemia].
Nakajima T; Masuda H; Okamoto T; Watanabe M; Yokoyama K; Yamada N; Tsukagoshi S; Taguchi T
Gan To Kagaku Ryoho; 1991 Apr; 18(4):555-62. PubMed ID: 2012397
[TBL] [Abstract][Full Text] [Related]
20. [Combination effects of etoposide with other antitumor drugs in vitro and in vivo].
Nishikawa K; Kusama K; Ekimoto H; Takahashi K
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3739-45. PubMed ID: 2596858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
